Preclinical Research

  • Preclinical Research
  • Expert Support for Your IND/CTA Requirements

    Partnering with Altasciences for your IND/CTA needs will ensure that your application to regulatory agencies moves forward as smoothly and efficiently as possible. To reach your milestones on time, we recommend setting up a meeting to consult with us at least one year before your targeted IND/CTA submission date to allow for program design and ordering of research animals. 

    Contact our experts today

    Altasciences can help you compile the key information necessary to approve your application request, including: 

    • Animal pharmacology and toxicology studies to assess safety; 
    • Manufacturing processes to ensure consistent batches of the study drug; 
    • Clinical protocols and investigator information to assess tolerance and risk. 

    For a more detailed overview of the regulatory planning process, consult our Preclinical Assessment Planning Guide

    You may also be interested in the following: 

    Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.

    Altasciences' Proactive Drug Development Solution: Biologics

    Development of a Flow Cytometry Phospho-STAT5 Assay in Nonhuman Primate T Cells

    Strategies for Reducing the Number of Animals in Toxicity Testing: A Comparative Approach for Rodent and Large Animal Studies

    Gene Therapy Utilizing Adeno-Associated Viral (AAV) Vectors: Historical Data Review to Characterize Common Challenges and Identify Opportunities for Refinement

    Comparison of Toxicology Assessment Baseline Data Collected Using Two Restraint Methods in Nonhuman Primates: Restraint Chair/Pole and Collar vs. Procedure Cage

    Downsized Sinclair™ vs. Göttingen™ Minipigs Similarities and Differences of Toxicological Reference Range Data in Preclinical Safety Studies

    Ocular Imaging and Microscopic Analysis of Focal Chorioretinal Defects in Rabbits

    Validation of an SC5b-9 Commercial Kit for Preclinical Biomarker Analysis

    Subscribe to Preclinical Research